Clinical trials: Heptocellular Cancer, open to volunteers
Heptocellular Cancer
Radioembolization Versus External Radiation Therapy
The proposed study is a single site, prospective, randomized phase 2 study to evaluate the efficacy and tolerability transarterial radioembolization (TARE) versus stereotactic body radiation therapy (SBRT) for hepatocellular…
- Trial name
- REVERT (NCT07530172)
- Testing
- Transarterial Radioembolization, Stereotactic Body Radiation Therapy (SBRT)
- Where
- United States
- Volunteers
- 146 people
- Sponsor
- Henry Ford Health System